Document is current
Any future updates will be listed below
-
Authors
Shamloo, Maryam
Mollard, Rebecca
Wang, Haizhou
Kingra, Kulwant
Tangri, Navdeep
MacKay, Dylan https://orcid.org/0000-0002-0751-1634
-
Funding
Funding for this research was provided by:
Garfield Weston Foundation
Mitacs (IT15871)
- License Information
-
More Information
Article History
Received: 12 August 2021
Accepted: 6 January 2022
First Online: 24 January 2022
Declarations
:
: The Bannatyne Campus Biomedical Research Ethics Board (BREB) in Winnipeg, Manitoba, Canada, has approved this study protocol (HS23161 (B2019:089). All amendments to this study’s protocol are reviewed and approved by the U of M BREB, and changes to the protocol are updated on ClinicalTrials.gov. Health Canada has issued the Notice of Authorization for this trial (File No. 250522). Participants must personally sign and date the latest approved version of the informed consent form before any trial-specific procedures are performed. This trial is registered at ClinicalTrials.gov (NCT04961164).
: All participants will provide consent to publish or present their information gathered during the trial in a fashion where their personal identifying information such as their name, address, and telephone number is not revealed.
: All other authors declare that they have no competing interests.
